"The Renewal of Cancer Immunotherapy" by top immunotherapy group & likely EMA reviewers: "they observed that patients who received DCVax-L survived for years after completing their vaccine doses, which could be due to an effective memory immune response"
Take a careful look at NOTE #7 : ALL are recognized top notch immuno oncology neuro surgeons affiliated with NWBO’s completed PH3 DCVAX L trial. https://www.mdpi.com/2076-393X/11/3/592
News 
Market Data 
Discover 
